Acknowledgement of Receipt of Information Sample Clauses

Acknowledgement of Receipt of Information. The Investor has had an opportunity to ask questions and receive answers and materials, and to discuss the business of the Company and its Subsidiaries and related matters, with certain key officers of the Company and its Subsidiaries regarding the transactions contemplated hereunder (the “Investigation”). The Investor hereby acknowledges and agrees that other than the Company’s representations and warranties set forth in Section 3.1, neither the Company nor any of its representatives makes or has made any representation or warranty, express or implied, at law or in equity, with respect to the business of the Company or any Subsidiary thereof nor with respect to the Shares. Nothing in this Section 3.2(d)(v) (including any information provided to the Investor by the Company pursuant to the Investigation) shall derogate from the representations and warranties of the Company contained in Section 3.1 hereof or from the ability of Investor to rely on such representations and warranties or to seek indemnification for Losses in respect of such representations and warranties.
Sample 1Sample 2See All (5)
AutoNDA by SimpleDocs
Acknowledgement of Receipt of Information. The Purchaser has had an opportunity to ask questions and receive answers and materials, and to discuss the business of the Company and related matters, with certain key officers of the Company regarding the transactions contemplated hereby. The Purchaser hereby acknowledges and agrees that other than the Company’s representations and warranties set forth in Section 3.1 hereof, neither the Company nor any of its representatives makes or has made any representation or warranty, express or implied, at law or in equity, with respect to the business of the Company nor with respect to the Issuable Shares.
Sample 1Sample 2Sample 3
Acknowledgement of Receipt of Information. I confirm that I have received from Wilsons a written disclosure of information relating to employees affected by the restructuring of Wilsons’ senior management, which includes the job titles and ages of senior managers who are being offered severance pay in exchange for a release of claims and information about senior managers who are not being offered severance pay, and that I understand the information contained on such disclosure.
Sample 1Sample 2
Acknowledgement of Receipt of Information. Purchaser has had an opportunity to ask questions and receive answers and materials, and to discuss the business of the Company and its Subsidiaries and related matters, with certain key officers of the Company and its Subsidiaries regarding the transactions contemplated hereunder (the “Investigation”). Purchaser hereby acknowledges and agrees that other than the Company’s representations and warranties set forth in Article III and the Seller's representations and warranties set forth in Article V hereof, none of the Company or the Seller or any of their representatives make or have made any representation or warranty, express or implied, at Law or in equity, with respect to the business of the Company or any Subsidiary thereof nor with respect to the Subject Shares. Nothing in this Section 4.4(f) (including any information provided to the Purchaser by the Company pursuant to the Investigation) shall derogate from the representations and warranties of the Company contained in Article III hereof or the representations and warranties of the Seller contained in Article V, or from the ability of Purchaser to rely on such representations and warranties or to seek indemnification for Losses in respect of such representations and warranties under Article IX.
Sample 1
Acknowledgement of Receipt of Information. Such Significant Shareholder has been furnished with materials relating to Parent and has been given the opportunity to ask questions of and receive answers from Parent, or from a person or persons acting on Parent's behalf, concerning the terms and conditions of this investment.
Sample 1
Acknowledgement of Receipt of Information. Without derogating from the representations and warranties of the Company contained in ARTICLE 2 hereof, the Acquirer acknowledges and agrees that it has, or its Representatives have, had an opportunity to ask questions and receive answers and materials, and to discuss the Company’s business, with certain key officers and employees of the Company and its Subsidiaries as well as advisors, and conducted its own independent investigation of the Company and its Subsidiaries, their respective businesses and the Transactions contemplated hereunder.
Sample 1
Acknowledgement of Receipt of Information. By signing this Agreement, you acknowledge that you have received SurModics, Inc.’s Separation Pay and Benefits Eligibility Disclosure (the “Disclosure”), attached hereto as Exhibit A, which sets forth (a) information relating to employees in your decisional unit (as described in the Disclosure) who are being offered separation benefits in exchange for signing, not rescinding and otherwise complying with a separation and release agreement and (b) information relating to employees in your decisional unit who were considered but who are not eligible to receive such separation benefits in connection with the reduction in force. You acknowledge that you have reviewed and understand the information contained in the Disclosure.
Sample 1
AutoNDA by SimpleDocs
Acknowledgement of Receipt of Information. Hospice services and the plan of care have been read and explained to me. I have been given ample opportunity to ask questions, and all of my questions have been answered to my satisfaction. I understand all the options available to me and after careful consideration and discussion regarding hospice care, I freely choose A1KARE HOSPICE AND PALLIATIVE CARE INC. to provide my hospice care. I acknowledge receipt of the following materials and information: 🞏 Informed Consent and Treatment Authorization 🞏 Medicare/Medicaid Hospice Benefit Election 🞏 Client financial responsibility/insurance verification 🞏 written material explaining Advance Directives, Durable Power of Attorney for Healthcare 🞏 California Out of Hospital Do Not Resuscitate Orders (POLST) 🞏 Information regarding the Grievance/Complaint procedure for the hospice 🞏 California Department of Public Health (DPH) phone number for any concerns 🞏 CDPH Complaints Line Information for any safety concerns. 🞏 Patient/Family Bill of Rights and Responsibilities 🞏 Information regarding company’s policy for Abuse/Neglect/Exploitation 🞏 Hospice’s Notice of Privacy Practices 🞏 Information on disposal of medications 🞏 Information on disposal of sharps 🞏 Information on hand hygiene, cough etiquette, oxygen home safety, flu program and fall prevention Patient’s Signature: Date: If Patient is unable to sign, state reason: Name & Signature of legally authorized representative (if applicable): Relationship: Employee: (Last, First) Signature: Discipline:
Sample 1
Acknowledgement of Receipt of Information. I acknowledge that I received the Disclosure from BWW at the same time I received this Release. I have reviewed and understand the information contained in the Disclosure.
Sample 1

Related to Acknowledgement of Receipt of Information

  • ACKNOWLEDGEMENT OF RECEIPT Each of the parties acknowledges receiving an executed copy of this Agreement.

  • Acknowledgement of Rights The Company acknowledges that, with respect to any Securities held by UCBH Trust Co. or a trustee of such trust, if the Property Trustee of such Trust fails to enforce its rights under this Indenture as the holder of the Securities held as the assets of UCBH Trust Co. any holder of Capital Securities may institute legal proceedings directly against the Company to enforce such Property Trustee's rights under this Indenture without first instituting any legal proceedings against such Property Trustee or any other person or entity. Notwithstanding the foregoing, if an Event of Default has occurred and is continuing and such event is attributable to the failure of the Company to pay principal of or premium, if any, or interest on the Securities when due, the Company acknowledges that a holder of Capital Securities may directly institute a proceeding for enforcement of payment to such holder of the principal of or premium, if any, or interest on the Securities having a principal amount equal to the aggregate liquidation amount of the Capital Securities of such holder on or after the respective due date specified in the Securities.

  • Acknowledgement 5. Staff and the Respondent agree with the facts set out in Part IV herein for the purposes of this Settlement Agreement only and further agree that this agreement of facts is without prejudice to the Respondent or Staff in any other proceeding of any kind including, but without limiting the generality of the foregoing, any proceedings brought by the MFDA (subject to Part IX) or any civil or other proceedings which may be brought by any other person or agency, whether or not this Settlement Agreement is accepted by the Hearing Panel.

  • Acknowledgement and Agreement By execution below, the Transferor expressly acknowledges and consents to the pledge of the 2010-1 SUBI Certificate and the 2010-1 SUBI and the assignment of all rights and obligations of the Transferor related thereto by the Transferee to the Indenture Trustee pursuant to the Indenture for the benefit of the Noteholders. In addition, the Transferor hereby acknowledges and agrees that for so long as the Notes are Outstanding, the Indenture Trustee will have the right to exercise all powers, privileges and claims of the Transferee under this Agreement.

  • Dissemination of Research Findings and Acknowledgement of Controlled-Access Datasets Subject to the NIH GDS Policy It is NIH’s intent to promote the dissemination of research findings from use of controlled-access dataset(s) subject to the NIH GDS Policy as widely as possible through scientific publication or other appropriate public dissemination mechanisms. Approved Users are strongly encouraged to publish their results in peer-reviewed journals and to present research findings at scientific meetings.

  • Acknowledgement and Waiver 6.1 The Subscriber has acknowledged that the decision to purchase the Shares was solely made on the Company Information. The Subscriber hereby waives, to the fullest extent permitted by law, any rights of withdrawal, rescission or compensation for damages to which the Subscriber might be entitled in connection with the distribution of any of the Shares.

  • ACKNOWLEDGEMENT OF ADDENDA The Bidder shall acknowledge receipt of any addenda issued to this solicitation by completing the blocks below or by completion of the applicable information on the addendum and returning it not later than the date and time for receipt of the bid. Failure to acknowledge an addendum that has a material impact on this solicitation may negatively impact the responsiveness of your bid. Material impacts include but are not limited to changes to specifications, scope of work/services, delivery time, performance period, quantities, bonds, letters of credit, insurance, or qualifications. Addendum No. , Date Addendum No. , Date Addendum No. , Date Addendum No. , Date AUTHORIZED SIGNATORIES/NEGOTIATORS The Bidder represents that the following principals are authorized to sign bids, negotiate and/or sign contracts and related documents to which the bidder will be duly bound. Principal is defined as an employee, officer or other technical or professional in a position capable of substantially influencing the development or outcome of an activity required to perform the covered transaction. Name Title Telephone Number/Email (Signature) (Date) (Title) (Name of Business) The Bidder shall complete and submit the following information with the bid: Type of Organization Sole Proprietorship Partnership Non-Profit Joint Venture* Corporation State of Incorporation: Principal Place of Business (Florida Statute Chapter 607): City/County/State THE PRINCIPAL PLACE OF BUSINESS SHALL BE THE ADDRESS OF THE BIDDER’S PRINCIPAL OFFICE AS IDENTIFIED BY THE FLORIDA DIVISION OF CORPORATIONS. Federal I.D. number is: * Joint venture firms must complete and submit with their Bid Response the form titled “Information for Determining Joint Venture Eligibility”, and a copy of the formal agreement between all joint venture parties. This joint venture agreement must indicate the parties’ respective roles, responsibilities and levels of participation for the project. If proposing as a Joint Venture, the Joint Venture shall obtain and maintain all contractually required insurance in the name of the Joint Venture as required by the Contract. Individual insurance in the name of the parties to the Joint venture will not be accepted. Failure to timely submit the required form along with an attached written copy of the joint venture agreement may result in disqualification of your Bid Response

  • ACKNOWLEDGEMENT OF TERMS The Company hereby represents and warrants to the Investor that: (i) it is voluntarily entering into this Agreement of its own freewill, (ii) it is not entering this Agreement under economic duress, (iii) the terms of this Agreement are reasonable and fair to the Company, and (iv) the Company has had independent legal counsel of its own choosing review this Agreement, advise the Company with respect to this Agreement, and represent the Company in connection with this Agreement.

  • ACKNOWLEDGEMENT AND CONFIRMATION Each party to this Amendment hereby confirms and agrees that, after giving effect to this Amendment and the amendments contemplated hereby, and except as expressly modified hereby, the Credit Agreement and the other Credit Documents to which it is a party remain in full force and effect and enforceable against such party in accordance with their respective terms and shall not be discharged, diminished, limited or otherwise affected in any respect.

  • Certain Acknowledgements The Participant acknowledges and agrees (i) that the Trust, the Transfer Agent, the Distributor and their respective agents may elect to review any Order placed through the Web Order Site manually before it is executed and that such manual review may result in a delay in execution of such Order; (ii) that during periods of heavy market activity or other times, it may be difficult to place Orders via the Web Order Site and the Participant may place Orders as otherwise set forth in Attachment A; and (iii) that any transaction information, content, or data downloaded or otherwise obtained through the use of the Web Order Site are done at the Participant’s own discretion and risk. EXCEPT AS OTHERWISE SPECIFICALLY PROVIDED IN THE FUND CONNECT AGREEMENT AND TO THE EXTENT PERMITTED BY APPLICABLE LAW, THE PARTICIPANT ACKNOWLEDGES AND AGREES THAT THE WEB ORDER SITE IS PROVIDED “AS IS,” “AS AVAILABLE” WITH ALL FAULTS AND WITHOUT ANY WARRANTY OF ANY KIND. SPECIFICALLY, WITHOUT LIMITING THE FOREGOING, ALL WARRANTIES, CONDITIONS, OTHER CONTRACTUAL TERMS, REPRESENTATIONS, INDEMNITIES AND GUARANTEES WITH RESPECT TO THE WEB ORDER SITE, WHETHER EXPRESS, IMPLIED OR STATUTORY, ARISING BY LAW, CUSTOM, PRIOR ORAL OR WRITTEN STATEMENTS BY THE TRUST, THE TRANSFER AGENT, THE DISTRIBUTOR OR THEIR RESPECTIVE AGENTS, AFFILIATES, LICENSORS OR OTHERWISE (INCLUDING, BUT NOT LIMITED TO AS TO TITLE, SATISFACTORY QUALITY, ACCURACY, COMPLETENESS, UNINTERRUPTED USE, NON-INFRINGEMENT, TIMELINESS, TRUTHFULNESS, SEQUENCE, COMPLETENESS, MERCHANTABILITY OR FITNESS FOR PARTICULAR PURPOSE AND ANY IMPLIED WARRANTIES, CONDITIONS AND OTHER CONTRACTUAL TERMS ARISING FROM TRADE USAGE, COURSE OF DEALING OR COURSE OF PERFORMANCE) ARE HEREBY OVERRIDDEN, EXCLUDED AND DISCLAIMED.

Time is Money Join Law Insider Premium to draft better contracts faster.